LOGO
LOGO

Intraday Alerts

Cue Biopharma Stock Soars 100%

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of Cue Biopharma, Inc. (CUE) are soaring about 100 percent in Friday morning trading, likely driven by several significant announcements the company made yesterday.

The company's shares are currently trading at $29.59 on the Nasdaq, up 100.62 percent. The stock opened at $33.80 in today's session. Over the past year, it has traded in a range of $4.98 to $33.80.

The company announced the appointment of Shao-Lee Lin to succeed Lucinda Warren, Interim President and Chief Executive Officer. Also, it agreed to sell pre-funded warrants to purchase upto 2.73 million shares and accompanying warrants to purchase an aggregate of up to 1.36 million shares at the price of $11.00 per pre-funded warrant and accompanying warrant.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.